切除修复交叉互补酶1等常见耐药相关蛋白在伴神经侵犯胃癌中的表达
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金资助项目(81301765);江苏省青年医学重点人才项目(QNRC2016829);镇江市科技计划项目(SH2015054,SH2016038);江苏大学附属医院“5123”人才计划(51232017301)


Expression of chemotherapy resistance associated proteins including excision repair cross⁃complementation group 1 in gastric cancer patients with perineural invasion
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:检测切除修复交叉互补酶1(excision repair cross-complementation group 1,ERCC1)等常见耐药相关蛋白在伴神经侵犯胃癌患者中的表达。方法:回顾性分析242例胃腺癌患者的临床资料,免疫组化染色检测肿瘤组织中ERCC1、微管蛋白β3、胸苷酸合酶(thymidylate synthase,TS)、DNA拓扑异构酶2(topoisomerase 2-alpha,TOP2A)及P 糖蛋白的蛋白表达水平,比较有和无神经侵犯者上述分子标志物表达的差异。结果:108例(44.6%)有神经侵犯,其肿瘤最大径≥5 cm、低分化、伴肿瘤脉管侵犯及TNM分期Ⅲ~Ⅳ期的比例均显著高于无神经侵犯者(P < 0.05)。伴神经侵犯者的ERCC1高表达率显著高于无神经侵犯者(63.9% vs. 46.5%,P < 0.05),而其他耐药相关蛋白的高表达率在两组间均无统计学差异(P > 0.05)。亚组分析显示,有和无神经侵犯者之间ERCC1高表达率的差异主要出现于男性(64.8% vs. 43.1%,P=0.026)和肿瘤低分化的患者中(76.3% vs. 42.9%,P=0.006)。结论:伴神经侵犯胃癌患者的ERCC1蛋白表达水平升高,提示了神经侵犯影响化疗疗效的可能原因。

    Abstract:

    Objective:To investigate the expressions of proteins associated with chemotherapy resistance including excision repair cross-complementation group 1(ERCC1) in gastric cancer patients perineural invasion(PNI). Methods:A retrospective study was conducted in 242 patients with gastric adenocarcinoma. The expressions of tubulin β3,thymidylate synthase(TS),P-glycoprotein,topoisomerase 2-alpha(TOP2A) and ERCC1 were detected by immunohistochemistry in paraffin-embedded tumor tissues and were compared between patients with and without PNI. Results:PNI was detected in 108 patients(44.6%),and the proportions of patients with the longest diameter of tumor ≥5 cm,poor histological differentiation,lymphovascular invasion and TNM stages of Ⅲ~Ⅳ were significantly higher in these patients than those in patients without PNI(P < 0.05). The high expression rate of ERCC1 in patients with PNI was significantly higher than those in those without PNI(63.9% vs. 46.5%,P < 0.05),and this difference was mainly found in subgroups of male(64.8% vs. 43.1%,P=0.026) and poor differentiation(76.3% vs. 42.9%,P=0.006). The high expression rates of tubulin β3,TS,P-glycoprotein and TOP2A were not significantly different between these two groups(P > 0.05). Conclusion:Gastric cancer patients with PNI had an increased expression level of ERCC1 protein,indicating the possible mechanism of poor chemotherapy effect induced by PNI.

    参考文献
    相似文献
    引证文献
引用本文

戴东方,陈德玉,李小琴,顾汉刚,陶 清,王德强.切除修复交叉互补酶1等常见耐药相关蛋白在伴神经侵犯胃癌中的表达[J].南京医科大学学报(自然科学版),2019,(11):1584-1588

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2019-04-15
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-12-02
  • 出版日期: